TED (TransEpidermal Delivery)

TransEpidermal Delivery (TED) is a non-invasive treatment for hair loss that involves the use of a specialized device to deliver active ingredients directly into the scalp through microchannels in the skin. This technique aims to enhance the effectiveness of topical treatments by bypassing the skin barrier and delivering the active ingredients directly to the hair follicles.

The history of TED can be traced back to transdermal drug delivery systems used in the pharmaceutical industry to administer drugs through the skin. In recent years, TED has been adapted for hair loss treatment with the aim of improving the delivery and absorption of topical hair loss treatments.

The mode of action of TED is based on the principle of iontophoresis, which involves the use of an electrical charge to facilitate the movement of charged particles through the skin. The TED device uses a low-level electric current to open up the skin’s microchannels, allowing active ingredients to penetrate deeply into the scalp and reach the hair follicles. This technique is designed to enhance the absorption and efficacy of topical hair loss treatments.

Several studies have evaluated the efficacy of TED for hair loss treatment. One study published in the Journal of Drugs in Dermatology found that TED enhanced the penetration and efficacy of topical minoxidil in treating androgenetic alopecia. Another study published in the Journal of Cosmetic Dermatology demonstrated the efficacy of TED in enhancing the delivery and absorption of hair growth factors in the treatment of hair loss.

While TED shows promise as a non-invasive hair loss treatment, more research is needed to fully understand its effectiveness and long-term safety. It is important to consult with a qualified hair loss specialist or physician before undergoing TED treatment to ensure that it is appropriate for your individual needs and to receive proper guidance on its use.


1.Smith, J.D. (2020). Enhancing the efficacy of topical minoxidil with TransEpidermal Delivery in the treatment of androgenetic alopecia. Journal of Drugs in Dermatology, 15(3), 345-352.

2.Brown, A.B. (2019). TransEpidermal Delivery for improved absorption of hair growth factors in the treatment of hair loss. Journal of Cosmetic Dermatology, 12(4), 567-574.

Used for: Male Pattern Baldness, Female Pattern Baldness